Q32 Bio (QTTB) Equity Ratio (2017 - 2025)
Q32 Bio (QTTB) has 9 years of Equity Ratio data on record, last reported at 0.68 in Q4 2025.
- For Q4 2025, Equity Ratio rose 1006.52% year-over-year to 0.68; the TTM value through Dec 2025 reached 0.68, up 1006.52%, while the annual FY2025 figure was 0.68, 1006.52% up from the prior year.
- Equity Ratio reached 0.68 in Q4 2025 per QTTB's latest filing, up from 0.32 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.87 in Q2 2021 and bottomed at 3.89 in Q4 2023.
- Average Equity Ratio over 5 years is 0.01, with a median of 0.22 recorded in 2024.
- Peak YoY movement for Equity Ratio: tumbled 579.44% in 2023, then soared 1006.52% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.8 in 2021, then tumbled by 171.4% to 0.57 in 2022, then crashed by 579.44% to 3.89 in 2023, then surged by 101.58% to 0.06 in 2024, then surged by 1006.52% to 0.68 in 2025.
- Per Business Quant database, its latest 3 readings for Equity Ratio were 0.68 in Q4 2025, 0.32 in Q3 2025, and 0.19 in Q2 2025.